首页> 美国卫生研究院文献>Stem Cell Reports >Genetic and Chemical Screenings Identify HDAC3 as a Key Regulator in Hepatic Differentiation of Human Pluripotent Stem Cells
【2h】

Genetic and Chemical Screenings Identify HDAC3 as a Key Regulator in Hepatic Differentiation of Human Pluripotent Stem Cells

机译:遗传和化学筛选确定HDAC3是人类多能干细胞肝分化中的关键调控因子

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

class="head no_bottom_margin" id="sec1title">IntroductionHuman pluripotent stem cells (hPSCs) hold great promise as an attractive resource of human somatic cells, due to their ability to self-renew and, theoretically, to differentiate into any of the myriad of somatic cell types in the human body. In practice, the ability to differentiate into a desired cell type often depends on the availability of an efficient protocol. Stepwise protocols using defined factors have been established years ago for the differentiation from hPSCs toward human hepatocytes (, , ). However, the resulting hepatocytes exhibit an immature hepatic phenotype (e.g., express fetal markers such as alpha fetoprotein) and remain a heterogeneous population. In addition, substantial variation in differentiation efficiencies has been observed among different hPSC lines. Considerable effort has later been devoted to studying the directed differentiation process or screening for compounds for enhanced maturation of HLCs (, , , ). While many of the improvements to the hepatic differentiation protocol are based on the knowledge acquired in understanding signal pathways that control embryonic lineage bifurcations, none of the existing studies tackled the differentiation problems through an unbiased genetic screening approach. With recent advances in genome editing technologies, especially the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) system, genome-wide genetic screening becomes a high-throughput, low-cost platform that enables comprehensive study of regulators in a biological process (). In the present study, we devised a reporter system and applied a CRISPR/Cas9-based genetic screening approach to identify potential regulators in hepatic lineage determination. Based on the results from the genetic screening, we also performed a targeted, small-scale chemical screening. We have identified several regulators in hepatic differentiation and an efficient small molecule that can improve the differentiation efficiency. Our study also demonstrated a broadly useful approach for studying hPSC differentiation.
机译:<!-fig ft0-> <!-fig @ position =“ anchor” mode =文章f4-> <!-fig mode =“ anchred” f5-> <!-fig / graphic | fig / alternatives / graphic mode =“ anchored” m1-> class =“ head no_bottom_margin” id =“ sec1title”>简介人类多能干细胞(hPSC)具有诱人的人类体细胞来源,因为它们具有自我更新的能力,并且在理论上可以分化为人体中多种体细胞类型。在实践中,分化成所需细胞类型的能力通常取决于有效协议的可用性。几年前已经建立了使用定义因子的逐步方案,用于从hPSC分化为人肝细胞(,)。但是,所得的肝细胞表现出不成熟的肝表型(例如,表达胎儿标记物,例如甲胎蛋白)并保持异质群体。另外,已经观察到不同hPSC品系之间分化效率的显着变化。后来,人们投入了大量精力来研究定向分化过程或筛选可增强HLC成熟的化合物(“,,,”)。尽管对肝分化方案的许多改进都是基于了解控制胚胎谱系分支的信号途径中获得的知识,但现有的研究均未通过无偏遗传筛选方法解决分化问题。随着基因组编辑技术的最新发展,特别是簇状规则间隔的短回文重复序列(CRISPR)/ CRISPR相关(Cas)系统,全基因组遗传筛选成为一个高通量,低成本平台,可对调节基因进行全面研究。生物过程()。在本研究中,我们设计了一种报告基因系统,并应用了基于CRISPR / Cas9的基因筛选方法来鉴定肝谱系确定中的潜在调控因子。根据遗传筛选的结果,我们还进行了有针对性的小规模化学筛选。我们已经确定了肝分化中的几种调节剂和一种可以提高分化效率的有效小分子。我们的研究还证明了用于研究hPSC分化的广泛有用的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号